These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 24501735)

  • 1. Treatment-refractory depression: a case of successful treatment with intranasal ketamine 10%.
    Clark P
    Ann Clin Psychiatry; 2014 May; 26(2):145. PubMed ID: 24501735
    [No Abstract]   [Full Text] [Related]  

  • 2. Time until relapse after augmentation with single-dose ketamine in treatment-resistant depression.
    Pérez-Esparza R; Corona T; Ruiz-García RG; Oñate-Cadena N; de la Fuente-Sandoval C; Ramírez-Bermúdez J
    Psychiatry Clin Neurosci; 2018 Aug; 72(8):623. PubMed ID: 29744959
    [No Abstract]   [Full Text] [Related]  

  • 3. Ketamine safety and tolerability in clinical trials for treatment-resistant depression.
    Wan LB; Levitch CF; Perez AM; Brallier JW; Iosifescu DV; Chang LC; Foulkes A; Mathew SJ; Charney DS; Murrough JW
    J Clin Psychiatry; 2015 Mar; 76(3):247-52. PubMed ID: 25271445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ketamine-induced affective switch in a patient with treatment-resistant depression.
    Banwari G; Desai P; Patidar P
    Indian J Pharmacol; 2015; 47(4):454-5. PubMed ID: 26288483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of action of ketamine.
    Stahl SM
    CNS Spectr; 2013 Aug; 18(4):171-4. PubMed ID: 23866089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pilot dose-response trial of i.v. ketamine in treatment-resistant depression.
    Lai R; Katalinic N; Glue P; Somogyi AA; Mitchell PB; Leyden J; Harper S; Loo CK
    World J Biol Psychiatry; 2014 Sep; 15(7):579-84. PubMed ID: 24910102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ameliorating treatment-refractory depression with intranasal ketamine: potential NMDA receptor actions in the pain circuitry representing mental anguish.
    Opler LA; Opler MG; Arnsten AF
    CNS Spectr; 2016 Feb; 21(1):12-22. PubMed ID: 25619798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in PAS-induced neuroplasticity after a treatment course of intranasal ketamine for depression. Report of three cases from a placebo-controlled trial.
    Gálvez V; Nikolin S; Ho KA; Alonzo A; Somogyi AA; Loo CK
    Compr Psychiatry; 2017 Feb; 73():31-34. PubMed ID: 27886522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Repeated Ketamine Infusion Over Facial Emotion Recognition in Treatment-Resistant Depression: A Preliminary Report.
    Shiroma PR; Albott CS; Johns B; Thuras P; Wels J; Lim KO
    J Neuropsychiatry Clin Neurosci; 2015; 27(4):362-4. PubMed ID: 25658683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ketamine--a new treatment option for therapy-resistant depression].
    Köhler S; Betzler F
    Fortschr Neurol Psychiatr; 2015 Feb; 83(2):91-7. PubMed ID: 25723773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pilot Randomized Controlled Trial of Titrated Subcutaneous Ketamine in Older Patients with Treatment-Resistant Depression.
    George D; Gálvez V; Martin D; Kumar D; Leyden J; Hadzi-Pavlovic D; Harper S; Brodaty H; Glue P; Taylor R; Mitchell PB; Loo CK
    Am J Geriatr Psychiatry; 2017 Nov; 25(11):1199-1209. PubMed ID: 28739263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal drug delivery in neuropsychiatry: focus on intranasal ketamine for refractory depression.
    Andrade C
    J Clin Psychiatry; 2015 May; 76(5):e628-31. PubMed ID: 26035196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. All Suicidal Ideation Is Not Created Equal: Two Cases of Suicide Attempts During Maintenance Ketamine Treatment.
    Cusin C; Sakurai H; Bentley K; Pedrelli P; Foster S; Fava M; Mischoulon D
    Am J Psychiatry; 2020 Feb; 177(2):173-174. PubMed ID: 32008389
    [No Abstract]   [Full Text] [Related]  

  • 14. Happiness During Low-Dose Ketamine Infusion Predicts Treatment Response: Reexploring the Adjunctive Ketamine Study of Taiwanese Patients With Treatment-Resistant Depression.
    Chen MH; Lin WC; Wu HJ; Bai YM; Li CT; Tsai SJ; Hong CJ; Tu PC; Cheng CM; Su TP
    J Clin Psychiatry; 2020 Nov; 81(6):. PubMed ID: 33176071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral Ketamine in Treatment-Resistant Depression: A Clinical Effectiveness Case Series.
    Al Shirawi MI; Kennedy SH; Ho KT; Byrne R; Downar J
    J Clin Psychopharmacol; 2017 Aug; 37(4):464-467. PubMed ID: 28514237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New use for an old drug: oral ketamine for treatment-resistant depression.
    Swiatek KM; Jordan K; Coffman J
    BMJ Case Rep; 2016 Aug; 2016():. PubMed ID: 27489070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Repeated Intravenous Ketamine in Treatment-Resistant Geriatric Depression: A Case Series.
    Bryant KA; Altinay M; Finnegan N; Cromer K; Dale RM
    J Clin Psychopharmacol; 2019; 39(2):158-161. PubMed ID: 30742589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid effectiveness of intravenous ketamine for ultraresistant depression in a clinical setting and evidence for baseline anhedonia and bipolarity as clinical predictors of effectiveness.
    Thomas RK; Baker G; Lind J; Dursun S
    J Psychopharmacol; 2018 Oct; 32(10):1110-1117. PubMed ID: 30182797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ketamine for Treatment-Resistant Depression: A Gateway to Novel Treatment Approaches.
    Limandri BJ
    J Psychosoc Nurs Ment Health Serv; 2018 Oct; 56(10):11-14. PubMed ID: 30278095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-dose ketamine followed by daily D-Cycloserine in treatment-resistant bipolar depression.
    Kantrowitz JT; Halberstam B; Gangwisch J
    J Clin Psychiatry; 2015 Jun; 76(6):737-8. PubMed ID: 26132675
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.